Literature DB >> 3164334

Effect of modified Widman flap surgery and systemic tetracycline on the subgingival microbiota of periodontal lesions.

A D Haffajee1, J L Dzink, S S Socransky.   

Abstract

33 subjects with evidence of active destructive periodontal disease were treated by modified Widman flap surgery and systemic tetracycline (1 g/day for 21 days). Subgingival plaque samples were taken from 41 sites in 12 of these subjects before and 6 months after therapy for predominant cultivable microbiota studies. Mean pocket depth and attachment levels in the 41 sampled sites were 7.1 +/- 2.9 mm and 7.7 +/- 3.2 mm prior to therapy and 4.8 +/- 2.3 mm and 6.2 +/- 3.4 mm after therapy. B. melaninogenicus and V. parvula were more frequently detected in samples taken after therapy, while S. intermedius, S. morbillorum, S. uberis and W. recta were less frequently detected after therapy. A. actinomycetemcomitans were detected in 7 sites pretherapy and 1 site post therapy. The frequency of detection of B. gingivalis and B. intermedius was virtually unchanged. The mean levels of the Actinomyces sp., A. actinomycetemcomitans, B. gingivalis, B. intermedius, S. morbillorum, S. uberis and W. recta were decreased after therapy, while the mean levels of B. melaninogenicus, S. mitis, S. sanguis II and V. parvula were increased after therapy. V. parvula showed the greatest increase to 8.2% of the microbiota. In the second phase of the study, subgingival plaque samples from 94 sites in the 33 treated subjects were analyzed by predominant cultivable techniques. As a result of therapy, 24 sites exhibited attachment loss greater than 2 mm, 23 sites exhibited "gain" greater than 2 mm and the remaining 47 sites were considered to be unchanging.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164334     DOI: 10.1111/j.1600-051x.1988.tb01579.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  6 in total

1.  In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations.

Authors:  M J Pavicić; A J van Winkelhoff; J de Graaff
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

2.  Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen.

Authors:  M S Lantz; R D Allen; P Bounelis; L M Switalski; M Hook
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

3.  Differential cytokine patterns in mouse macrophages and gingival fibroblasts after stimulation with porphyromonas gingivalis or Escherichia coli lipopolysaccharide.

Authors:  Katy J Jones; Sanaz Ekhlassi; Dina Montufar-Solis; John R Klein; Jeremy S Schaefer
Journal:  J Periodontol       Date:  2010-09-15       Impact factor: 6.993

4.  Empyema thoracis and lung abscess due to Gemella morbillorum.

Authors:  C T da Costa; C Porter; K Parry; A Morris; A H Quoraishi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-01       Impact factor: 3.267

Review 5.  Newly delineated periodontal pathogens with special reference to selenomonas species.

Authors:  A Tanner; H D Bouldin; M F Maiden
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

6.  Use of monoclonal antibodies with neutralizing effects on toxic antigens from human bacterial plaque to detect specific bacteria by colony blotting.

Authors:  M Levine; F C Miller
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.